BioForward Wisconsin, the collective voice of Wisconsin’s robust and comprehensive biohealth cluster representing more than 220 member organizations, is thrilled to announce the election of three new board members, effective January 1, 2021.
Wisconsin has a uniquely diverse wealth of sectors that make up the Wisconsin biohealth region. BioForward serves all these sectors including research institutions, biotech, biopharma, digital health, medical devices, diagnostics, and healthcare organizations. BioForward strives to have a representative slate of industry leaders on the board to reflect the broad range of needs and the depth and breadth of the biohealth ecosystem.
“Having all of these leaders on the same board is an incomparable experience. As we continue to add different perspectives from all industry sectors through board member roles, we are empowered to offer additional value to fulfill member needs. We find new ways to market and strengthen the biohealth community, facilitate collaboration, and accelerate innovation,” says CEO Lisa Johnson.
BioForward welcomes the election of three new leaders to serve on the board of directors:
- Joshua Carson, Venture Associate, WARF
- Haiying Grunenwald, Ph.D., Director of Product Development, Illumina
- Thomas Lynch, Ph.D., Vice President, Client Services, Aldevron
These directors began serving their board terms on January 1, 2021.
They will be joining:
- Board President Jay Hill, CTO, MICT, and GM of HW Platforms, GE Healthcare
- Board Treasurer Jon Denissen, Senior Vice President, PPD
- Board Secretary Lisa Biegel, Executive Director, Global Lead- Safety Assessment, Covance
- Past President Nicolas Paris, Chief Executive Officer, Gilson
- Graham Brearley, Ph.D., General Manager, Catalent
- Nina Garlie, Interim Vice President, Advocate Aurora Health
- Cecilia Hillard, Associate Dean for Research, Medical College of Wisconsin
- Edward Ladwig, GM & VP of Chemistry Operations, Eurofins
- Mark Millar, Director and Business Head, Sterling Pharma
- Richard Moss, Senior Associate Dean, Basic Research, Biotechnology, and Graduate Studies, University of Wisconsin School of Medicine and Public Health
- Garrett Peterson, Principal/Chief Strategy Officer, Yahara Software
- Brad Pietz, Executive VP and Chief Laboratory Officer, Versiti
- Brad Schwartz, CEO, Morgridge Institute for Research
- Tammy Turek-Etienne, VP of Operations, Exact Sciences
- Janet White, Director of Strategic Portfolio Management, Promega
“With the continuity within our board and executive leadership and the new perspectives brought by our added colleagues, we enter 2021 with a strong plan in place for continuing to strengthen the biohealth industry and elevate and amplify our strengths in biomanufacturing,” stated Board President Jay Hill.
To learn more about the full board of directors, go here.
BioForward Wisconsin is the collective voice of Wisconsin’s robust and comprehensive biohealth cluster, representing more than 220 member organizations across an integrated network of health solution leaders, including research institutions, biotech, biopharma, digital health, medical devices, diagnostics, and healthcare organizations. It is an action-oriented association that focuses on initiatives to strengthen the state’s talent pipeline; collaborations to develop supply chain partnerships; educational and networking events to enhance professional development; and legislative advocacy to highlight the economic and social impact of the biohealth industry on the state, nation, and world.
Learn more about BioForward Wisconsin at www.bioforward.org.